BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25854682)

  • 21. Timing of postpartum intrauterine device placement: a cost-effectiveness analysis.
    Washington CI; Jamshidi R; Thung SF; Nayeri UA; Caughey AB; Werner EF
    Fertil Steril; 2015 Jan; 103(1):131-7. PubMed ID: 25439838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of intrauterine contraceptives].
    Parshina LA; Konishcheva OE
    Akush Ginekol (Mosk); 1977 Dec; (12):39-40. PubMed ID: 605979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of pre-eclampsia/Eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: a case control study.
    Grum T; Seifu A; Abay M; Angesom T; Tsegay L
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):307. PubMed ID: 28915802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research interest focuses on follow-up of IUD users.
    Netw Res Triangle Park N C; 1985; 6(3):5. PubMed ID: 12280133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of frameless anchored IUD for immediate intracesarean insertion.
    Wildemeersch D; Goldstuck ND; Hasskamp T
    Dev Period Med; 2016; 20(1):7-15. PubMed ID: 27416620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility after intrauterine device removal: a pilot study.
    Stoddard AM; Xu H; Madden T; Allsworth JE; Peipert JF
    Eur J Contracept Reprod Health Care; 2015 Jun; 20(3):223-30. PubMed ID: 25751567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility in older women following removal of long-term intrauterine devices in the wake of a natural disaster.
    Zhu H; Lei H; Huang W; Fu J; Wang Q; Shen L; Wang Q; Ruan J; Liu D; Song H; Hu L
    Contraception; 2013 Apr; 87(4):416-20. PubMed ID: 23246305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia.
    Trogstad LI; Eskild A; Magnus P; Samuelsen SO; Nesheim BI
    Int J Epidemiol; 2001 Dec; 30(6):1317-22. PubMed ID: 11821338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstetric outcome in women with epilepsy: a hospital-based, retrospective study.
    Borthen I; Eide MG; Daltveit AK; Gilhus NE
    BJOG; 2011 Jul; 118(8):956-65. PubMed ID: 21557799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine contraception after medical abortion: factors affecting success of early insertion.
    Pohjoranta E; Suhonen S; Mentula M; Heikinheimo O
    Contraception; 2017 Mar; 95(3):257-262. PubMed ID: 27836586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Health risks of intrauterine contraception (author's transl)].
    Keith LG; Berger GS; Edelman DA
    Contracept Fertil Sex (Paris); 1983 Jun; 11(6):801-8. PubMed ID: 12338737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of 52 pregnancies with intrauterine devices].
    Olivas Mendoza G; Hernández JG; Noriega Prieto JS; Castro Velarde RI; Thomas Del Río G; Inda Silva A
    Ginecol Obstet Mex; 1981 Apr; 49(294):255-62. PubMed ID: 7327423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine device failure: relation to its location within the uterine cavity.
    Anteby E; Revel A; Ben-Chetrit A; Rosen B; Tadmor O; Yagel S
    Obstet Gynecol; 1993 Jan; 81(1):112-4. PubMed ID: 8416443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of ultrasound in predicting success of intrauterine contraceptive device insertion immediately after delivery.
    Dias T; Abeykoon S; Kumarasiri S; Gunawardena C; Padeniya T; D'Antonio F
    Ultrasound Obstet Gynecol; 2015 Jul; 46(1):104-8. PubMed ID: 25418016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of abortion and subsequent risk of preeclampsia.
    Dempsey JC; Sorensen TK; Qiu CF; Luthy DA; Williams MA
    J Reprod Med; 2003 Jul; 48(7):509-14. PubMed ID: 12953325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for IUD failure: results of a large multicentre case-control study.
    Thonneau P; Almont T; de La Rochebrochard E; Maria B
    Hum Reprod; 2006 Oct; 21(10):2612-6. PubMed ID: 16775156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.